The aim was to identify adverse events arising from the continued use of 
.
Scientific publications were collected using to search the 
Results
Through the methodology were found 18 articles that fall within the established criteria (Table 1) . 
, it was found a higher risk of CI 95%] was evidenced in the casecontrol study of Imfeld et al. (18) with elderly patients using risperidone, quetiapine and olanzapine.
In case control study of Schemedt and Garbe (26) .
Yanik et al. (24) , in his casecontrol study, found an increase in BMI (body mass index) of patients using The AA were more effective in the acute treatment of schizophrenia.
There was less need for mechanical restraint with adult patients using risperidone and olanzapine. Compared with the AA group, the relative risk (RR) for the haloperidol group was 1.15 (95% CI, 0.95 -1.40, p¼ 0.15) (22) .
In Table 2 were cited other adverse events and associations identified in the articles. .
The atypical antipsychotics more used in the studies are olanzapine, risperidone and quetiapine. This is due to the highest frequency of use of these drugs compared to other atypical, this same relation is found in other studies (9, 12, 28) .
A study carried out in Santa Catarina showed that the antipsychotic haloperidol and risperidone presented 
Conclusion
In the study were not found cohort and case-control articles 
